Cardlytics, Inc. (LON:0LEC)
1.885
-0.114 (-5.72%)
At close: Aug 1, 2025
Theseus Pharmaceuticals Market Cap
Cardlytics has a market cap or net worth of 74.52 million as of August 1, 2025. Its market cap has decreased by -77.68% in one year.
Market Cap
74.52M
Enterprise Value
201.86M
Revenue
210.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.89
Market Cap Chart
Since February 9, 2018, Cardlytics's market cap has decreased from 189.05M to 74.52M, a decrease of -60.58%. That is a compound annual growth rate of -11.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 74.52M | -50.52% |
Dec 31, 2024 | 150.61M | -46.94% |
Dec 29, 2023 | 283.83M | 78.40% |
Dec 30, 2022 | 159.10M | -90.20% |
Dec 31, 2021 | 1.62B | -43.46% |
Dec 31, 2020 | 2.87B | 135.34% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Feb 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
The Sage Group | 11.38B |
Wise plc | 10.43B |
Spectris | 3.96B |
Softcat | 3.22B |
Computacenter | 2.34B |
Renishaw | 2.15B |
Alphawave IP Group | 1.37B |
Spirent Communications | 1.13B |